Emerging Chryseobacterium indologenes Infection in Indian Neonatal Intensive Care Units: A Case Report

Emerging Chryseobacterium indologenes Infection in Indian Neonatal Intensive Care Units: A Case Report

Blog Article

Antibiotic-resistant pathogens and nosocomial infections constitute common and serious problems for neonates Impact of the digital economy on the development of economic systems admitted to neonatal intensive care units worldwide.Chryseobacterium indologenes is a non-lactose-fermenting, gram-negative, health care-associated pathogen (HCAP).It is ubiquitous and intrinsically resistant to several antibiotics.

Despite its low virulence, C.indologenes has been widely reported to cause life-threatening infections.Patients on chronic immunosuppressant drugs, harboring invasive devices and indwelling catheters become the nidus for C.

indologenes.Typically, C.indologenes causes major health care-associated infections such as pneumonia, empyema, pyelonephritis, cystitis, peritonitis, meningitis, and bacteremia in patients harboring central venous catheters.

Management of C.indologenes infection Gas Transport in Shale Nanopores with Miscible Zone in neonates is not adequately documented owing to underreporting, particularly in India.Because of its multidrug resistance and the scant availability of data from the literature, the effective empirical treatment of C.

indologenes is challenging.We present an uncommon case of bacteremia caused by C.indologenes in a preterm newborn baby with moderate respiratory distress syndrome who was successfully treated.

We also provide a review of infections in the neonatal age group.Henceforth, in neonates receiving treatments involving invasive equipment use and long-term antibiotic therapy, multidrug resistant C.indologenes should be considered an HCAP.